SCHEDULE: Tom Kubota Increases Stake in Pacific Health Care

Tom Kubota, CEO of Pacific Health Care Organization Inc., has acquired an additional 65,258 shares, increasing his beneficial ownership to 66.3% of the company's common stock.

Summary

• Tom Kubota, CEO, President, and Chairman of Pacific Health Care Organization Inc., has filed an amendment to his Schedule 13D, reporting an increase in his beneficial ownership of the company's common stock.
• The filing indicates that as of May 27, 2026, Mr. Kubota acquired an additional 65,258 shares of common stock on the open market at $1.00 per share.
• His total beneficial ownership now stands at 8,491,258 shares, comprising 8,475,258 shares of common stock and 16,000 shares of Series A Preferred Stock.
• This ownership represents approximately 66.3% of the Issuer's common stock, calculated based on 12,800,000 shares outstanding as of March 31, 2026, and assuming conversion of his preferred stock.
• The Series A Preferred Stock is convertible into common stock on a one-for-one basis at the holder's election.
• Mr. Kubota states that these acquisitions were made with personal funds and were not for the purpose of changing control of the Issuer.
• He anticipates making additional acquisitions from time to time.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively due to the CEO's increased investment, signaling strong confidence. However, the high concentration of ownership is a neutral to slightly negative factor for broader investor appeal.

Positives

• Increased beneficial ownership by the CEO to 66.3%, indicating strong conviction and alignment with the company's performance.
• Acquisition of shares at $1.00 per share, suggesting a potentially undervalued stock price.
• CEO's continued investment signals confidence in the company's future prospects.
• The Series A Preferred Stock is convertible, offering flexibility and potential for further common stock ownership.

Negatives

• The concentration of ownership (66.3%) in a single individual could limit liquidity for other shareholders and potentially reduce the attractiveness for institutional investors.
• The filing is an amendment to a long-standing Schedule 13D, suggesting ongoing accumulation of shares rather than a new strategic event.

Risks

• Future acquisitions by the Reporting Person could further concentrate ownership.
• The potential for the Reporting Person to reconsider his position and formulate plans related to control or strategic transactions could introduce uncertainty.

Future Outlook

The Reporting Person anticipates making additional acquisitions from time-to-time and may, at any time, review or reconsider his position with respect to the Issuer and formulate plans or proposals with respect to various matters.

Management Comments

• The acquisitions were not for the purpose of changing control of the Issuer.
• The Reporting Person made the acquisitions because the shares were available for sell and he chose to acquire them.
• The Reporting Person anticipates he will make additional acquisitions from time-to-time.
• It is anticipated that future acquisitions by the Reporting Person would also not be for the purpose of effecting any of the transactions described in (b) through (j) of Item 4 of Schedule 13D.
• The Reporting Person may, at any time, review or reconsider his position with respect to the Issuer and formulate plans or proposals with respect to any of the matters described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

Industry Context

StockSavvy.ai notes that significant insider buying, especially by a CEO and Chairman, can be a strong signal of confidence in a company's future prospects, particularly in the healthcare sector where strategic positioning and operational efficiency are paramount. However, the high concentration of ownership warrants careful consideration by investors regarding market liquidity and potential governance dynamics.

Stakeholder Impact

• Shareholders: The high concentration of ownership by the CEO may limit the liquidity of shares for other investors and could influence future strategic decisions.
• Employees: Continued leadership by the CEO with a significant stake may provide stability, but also raises questions about future strategic direction and potential control changes.
• Creditors: The company's financial stability is indirectly supported by the CEO's continued investment, suggesting a commitment to the company's long-term viability.

Next Steps

• The Reporting Person may make additional acquisitions from time-to-time.
• The Reporting Person may review or reconsider his position and formulate future plans.

Key Dates

Recommendation

The filing indicates continued investment by the CEO, which is a positive signal. However, the lack of new strategic information, coupled with the already high concentration of ownership, suggests that the stock is likely to trade based on broader market and company performance rather than this specific filing. A 'hold' recommendation reflects the neutral impact of this amendment on the overall investment thesis.

Keywords

Pacific Health Care Organization Inc, Schedule 13D, Tom Kubota, Beneficial Ownership, Common Stock, Series A Preferred Stock, SEC Filing, Insider Trading, Shareholder, Corporate Governance